Press release

Current supervisory board members elected to new co-determined supervisory board of Siemens Healthineers AG

Annual Shareholders’ Meeting 2024
Published on April 18, 2024
  • Ralf P. Thomas confirmed as chair of the supervisory board 
  • Dorothea Simon and Karl-Heinz Streibich elected as deputy chairs of the supervisory board 
  • Dividend proposal of €0.95 per share for fiscal year 2023 approved 

At today’s annual shareholders’ meeting, Siemens Healthineers AG shareholders elected the members of the supervisory board who held office to date as shareholder representatives of the new supervisory board. 

The supervisory board will be co-determined for the first time and will in future comprise a total of 20 members. Shareholders also approved a dividend of €0.95 per share for fiscal year 2023, as proposed by the managing board and the supervisory board. The annual shareholders’ meeting also approved all other items on the agenda by a large majority. The actions of the managing board and the supervisory board in the past fiscal year were ratified by a large majority. The supervisory board, newly constituted immediately after the annual shareholders’ meeting, confirmed Ralf P. Thomas in his position as chair. Dorothea Simon, chair of the general works council was elected deputy chair in accordance with the Co-Determination Act, and Karl-Heinz Streibich as further deputy chair. 

“The new, co-determined supervisory board will monitor business activities across the whole of Siemens Healthineers, thus fully acknowledging and strengthening company co-determination in Germany,” said Ralf Thomas at the annual shareholders’ meeting. 

The new employee representatives on the supervisory board had been appointed by the court in advance, effective from the end of the annual shareholders’ meeting, whilst the previous supervisory board members were re-elected as shareholder representatives by the annual shareholders’ meeting. In total, the supervisory board initially consists of 16 members, half being shareholder representatives and half employee representatives. Once the amendment to the Articles of Association to increase the size of the supervisory board to 20 members, that was resolved on by the annual shareholders’ meeting, is entered into the commercial register, two additional supervisory board members will be added from each side. The former co-determined supervisory board at Siemens Healthcare GmbH level will cease to exist. 

The supervisory board appointed Darleen Caron, chief human resources officer and member of the managing board of Siemens Healthineers AG, as labor director. 

The publicly broadcast part of the virtual annual shareholders’ meeting was watched online by around 800 people, 94 questions were asked live by shareholders or their proxies via video and answered by the managing board and the supervisory board. 

The individual voting results on the agenda items of the annual shareholders’ meeting can be found here.

Further information on the Supervisory Board is available here.

Siemens Healthineers 2024

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2023, which ended on September 30, 2023, Siemens Healthineers had approximately 71,000 employees worldwide and generated revenue of around €21.7 billion. Further information is available at www.siemens-healthineers.com.